Details

Autor(en) / Beteiligte

• Pokorska-Śpiewak, Maria
• Talarek, Ewa
• Pawłowska, Małgorzata
• Mania, Anna
• Hasiec, Barbara
• Żwirek-Pytka, Elżbieta
• Stankiewicz, Magdalena
• Stani, Martyna
• Frańczak-Chmura, Paulina
• Szenborn, Leszek
• Zaleska, Izabela
• Chruszcz, Joanna
• Majda-Stanisławska, Ewa
• Dryja, Urszula
• Gąsiorowska, Kamila
• Figlerowicz, Magdalena
• Mazur-Melewska, Katarzyna
• Faltin, Kamil
• Ciechanowski, Przemysław
• Peregrym, Michał
• Łasecka-Zadrożna, Joanna
• Rudnicki, Józef
• Szczepańska, Barbara
• Pałyga-Bysiecka, Ilona
• Rogowska, Ewelina
• Hudobska-Nawrot, Dagmara
• Domańska-Granek, Katarzyna
• Sybilski, Adam
• Kucharek, Izabela
• Franczak, Justyna
• Sobolewska-Pilarczyk, Małgorzata
• Kuchar, Ernest
• Wronowski, Michał
• Paryż, Maria
• Kalicki, Bolesław
• Toczyłowski, Kacper
• Sulik, Artur
• Niedźwiecka, Sławomira
• Gorczyca, Anna
• Marczyńska, Magdalena

Titel

The Influence of SARS-CoV-2 Variants B.1.1.7 and B.1.617.2 on a Different Clinical Course and Severity of COVID-19 in Children Hospitalized in 2021 Compared With 2020

Ist Teil von

• The Pediatric infectious disease journal, 2023-07, Vol.42 (7), p.584-589

Ort / Verlag

United States

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• This study aimed to analyze the differences in the epidemiologic and clinical characteristics of coronavirus disease 2019 (COVID-19) in children hospitalized in 2021, when the severe acute respiratory syndrome coronavirus 2 variants B.1.1.7 (alpha) and B.1.617.2 (delta) dominated, compared with 2020. In this multicenter study based on the pediatric part of the national SARSTer register (SARSTer-PED), we included 2771 children (0-18 years) with COVID-19 diagnosed between March 1, 2020, and December 31, 2021, from 14 Polish inpatient centers. An electronic questionnaire, which addressed epidemiologic and clinical data, was used. Children hospitalized in 2021 were younger compared with those reported in 2020 (mean 4.1 vs. 6.8 years, P = 0 .01). Underlying comorbidities were reported in 22% of the patients. The clinical course was usually mild (70%). A significant difference in the clinical course assessment between 2020 and 2021 was found, with more asymptomatic patients in 2020 and more severely ill children in 2021. In total, 5% of patients were severely or critically ill, including <3% of the participants in 2020 and 7% in 2021. The calculated mortality rate was 0.1% in general and 0.2% in 2021. Infections with severe acute respiratory syndrome coronavirus 2 variants alpha and delta lead to a more severe course of COVID-19 with more pronounced clinical presentation and higher fatality rates than infection with an original strain. Most of the children requiring hospitalization due to COVID-19 do not have underlying comorbidities.